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Summary Magnetic resonance spectroscopy was used to study intracellular pH and compounds which
contain phosphorus in normal human brain and primary brain tumours non-invasively. In normal subjects
(n=7) intracellular pH (pHi) of the brain was 7.03+0.02 (mean±s.e.m.). The pHi did not vary between
superficial (2cm, majority grey matter) and deep brain (5cm, majority white matter). The relative
concentrations of phosphocreatine (PCr) and phosphomonoesters (PME) to ATP were also constant with
depth. The relative concentration of phosphodiesters (PDE) increased from superficial to deep in normal
brain. The astrocytomas (n =7, grade II-IV) were significantly more alkaline (pHi =7.08 +0.03), and contained
more PCr and PME, with respect to ATP, than normal brain at similar depth. The meningiomas (n =4) were
also more alkaline (pHi =7.19+0.02) with a raised PME level but reduced PCr. The reduction in meningioma
PCr may be due to the significant necrosis (>20 %) seen in the surgical biopsies. No significant necrosis was
seen in the gliomas. Previous in vitro studies suggest that increased PME may be due to accumulation of
phosphoethanolamine (PE), a phospholipid precursor. These results suggest that human primary brain
tumours characteristically are more alkaline with increased PME than normal brain.
Magnetic resonance spectroscopy (MRS) offers a non-
invasive, non-disruptive method of studying intra-cellular
metabolism in vivo. The development of wide bore magnets
has allowed 31P MRS to be applied to the study of tumours
in humans. Differences between the biochemistry of normal
and neoplastic tissues have been used to design optimum
forms of chemotherapy. This technique gives information on
phosphocreatine (PCr), ATP, inorganic phosphate (Pi) levels
and phosphomonester (PME) and phosphodiester (PDE)
containing compounds within the cell, and on intracellular
pH (pHi) (Radda, 1986).
PCr, ATP and Pi are compounds involved in energy
transfer within the cell. The intracellular levels of these
compounds are determined in part by the balance between
substrate supply and energy demand. PME and PDE peaks
contain signal derived from compounds which are involved
in phospholipid synthesis and degradation (Radda et al.,
1989). Relative levels of PME and PDE may reflect differing
rates of cell turnover. Animal and tissue culture tumour
models have been studied using phosphorus MRS (Daly et
al., 1987; Miceli et al., 1988). These studies have shown a
consistently raised PME peak within the neoplastic cell. The
PME peak was mainly composed of phosphoethanolamine
(PE), a precursor in phospholipid synthesis. Human studies
of neuroblastoma and other tumours in vivo have also found
a raised PME peak (Maris et al., 1985) and alkaline pHi
relative to normal tissue in some brain tumours (Oberhaensli
et al., 1986).
The aim of this study was to investigate the phosphorus
metabolism of normal brain and primary brain tumours and
relate biochemical differences to histological features seen in
the tumour biopsies taken within 24h of the MRS study.
The phase modulated rotating frame imaging (PMRFI)
technique was used (Blackledge et al., 1987) in which a
double surface coil, placed over the region of interest,
receives signal from a defined cylinder of tissue 6 cm in
diameter to a depth of 6cm. The cylinder is resolved into
small biconvex discs, approximately 6cm wide and 0.5cm
deep.
Materials and methods
Seven normal subjects (mean age 34 years, range 22-55),
seven patients with astrocytomas (mean age 41 years, range
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22-66) and four patients with meningiomas (mean age 61
years, range 48-72) were studied. Size and site of all tumours
were assessed by CT scan with contrast enhancement. The
astrocytomas were at least 4cm in diameter and within 4cm
of skull surface. The meningiomas were superficial convexity
tumours at least 6cm in diameter. Phosphorus spectra were
obtained from the patients 24 h before surgery. Tumour
samples taken at surgery were examined to confirm histo-
logical diagnosis and degree of necrosis, and graded accord-
ing to Kernohan's histological grading (Kernohan et al.,
1949). Ethical permission was granted for this study by the
local ethics committee, and informed consent was obtained
from all subjects.
All studies were performed using a 1.9 Tesla, 60cm bore
superconducting magnet (Oxford Magnet Technology) inter-
faced with a Bruker Biospec spectrometer. A double surface
coil, made from copper wire (4mm thick), with separate
transmitter (15cm diameter) and receiver (6.25cm diameter)
coils, was tuned for phosphorus at 32.701 MHz. The two
coils were isolated from each other using a circuit described
previously (Styles, 1988). In all studies the magnetic field
homogeneity was first optimised using the proton signal
from the region of brain to be studied.
The PMRFI technique has been described in detail else-
where (Blackledge et al., 1987). The pulse sequence consisted
of 0+x±, Ay, acquire, relaxation delay. The frequency encoding
pulse (0) was incremented in steps of 60 from 0 to (n -1)50,
where 60 was set at 350Ms, and n(18) was the total number
of increments. A, the phase encoding pulse, was set to equal
n/2 at the centre of the sample. Sixteen transients were
summed at each increment. The interpulse delay was 3.0s.
The spectral width was 2 kHz. To remove the phase twist
inherent in 2-D Fourier transforms, a second data set with
o-x was acquired in the manner described above. The free
induction decay was profiled to remove the broad signal
associated with bone (Gordon et al., 1982) and multiplied by
an exponential line broadening of 15Hz in the chemical shift
dimension. 2-D Fourier transform was performed after a line
broadening was applied in the spatial (Fl) dimension. This
was equivalent to setting the maximal resolution between
slices to 5mm in the spatial dimension. The two images
obtained with Ox and 0_x were then added after reversing
the second data set, 0, about the origin to produce an
image without a phase twist (Blackledge et al., 1987). The
resulting images are presented as contour plots and as
individual spectra at different depths.
The position of the receiver coil within the image was
identified by placing a small vial, containing 0.8ml of
100mmol -1 diphenyl phosphate in absolute ethanol, in the
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Figure 1 A five compartment phantom with each cavity 0.5cm deep, 10cm2, separated by 0.5cm thick glass, containing
lOOmmoll phosphate solutions, was used to define the resolution of the PMRFI technique. The first compartment (at lcm
from receiver coil) contained a solution of NaHPO4 at pH4; the second (at 2cm) contained NaHPO4 at pH 12; the third (at 3cm)
contained pyrophosphate at pH 10; the fourth (at 4cm) contained NaHPO4, at pH 7; and the final compartment (at 5cm)
contained NaHPO4 at pH4, as shown in a. The data set is presented as a contour plot (b) with intensity of signal plotted against
chemical shift (y axis) and distance (x axis), from which selected spectra (c) are taken and peak areas measured.
middle of the receiver coil. Spatial and chemical resolution
were tested using a multi-compartment phantom (Figure 1).
Lateral resolution was established by using a concentric
phantom with multiple concentric compartments (Figure 2).
A Lorentzian line fitting routine (Glinfit, Bruker) was used
to measure the chemical position and area of the peaks in
the phosphorus spectra at selected depths. PCr/ATP ratios
were calculated using the signal from the gamma phosphate
of ATP. Intracellular pHi measurements were made using
the chemical shift between PCr and Pi peaks (Taylor et al.,
1983). TI of PCr and ATP was measured using PMRFI with
inversion recovery (Blackledge et al., 1989) and found to be
4.0+0.4 s for PCr and 1.2+0.2 s for ATP. The PCr data were
corrected for the 3s interpulse delay used in these investi-
gations. P values were derived using the Wilcoxon two-
sample test for non-parametric, non-paired samples. Normal
ratios at 4cm depth were compared to metabolite ratios at
tumour centre, as assessed by CT scans. Variation within
groups was calculated as mean+standard error of the mean
(s.e.m.).
Results
Results from the multicompartment phantom demonstrate
that PMRFI can resolve signal from phosphorus com-
pounds, with a resolution of 0.5 cm with depth. These
calibration experiments and computer simulations show that
phosphorus signal is received from slices of brain in the
shape of a biconvex disc 6.5cm diameter and 0.5 cm deep,
with an approximate volume of 15cm3 where the diameter
of the discs increased from 6.5 cm in the superficial slices to
8 cm at 6cm from the receiver coil.
A typical data set from a normal subject is shown in
Figure 3. The image shows a raised PCr signal at cm
depth. PCr decreases to a depth of 3cm, beyond which the
PCr remains constant. The PDE increases with depth, while
pHi and PME remain constant. The data from all the
normal subjects are summarised in Table I. At 1 cm image
depth the PCr/ATP ratio is 3.38. This is consistent with the
spectra being derived from overlying temporalis muscle.
Human skeletal muscle has been shown to have a similar
b
-V
.E co e
0432 T.A.D. CADOUX-HUDSON et al.
a
b
E
0
.U
Concentric phantom
Depth (cm)
Figure 2 The concentric phantom (a) has four cylindrical
compartments, placed one within the other, each filled with a
different phosphate solution. The central compartment (0-5.5cm
diameter) contained water; the second (mean diameter 6.5cm)
contained pyrophosphate; the third (mean diameter 8.5cm) con-
tained NaHPO4 at pH 12; and the fourth (mean diameter 10cm)
contained NaHPO4 at pH4. Signal was received from a cylinder
with a diameter of 6.5 cm at cm from the receiver coil.
PCr/ATP ratio (Taylor et al., 1983). At 2cm depth, signal
from a mixture of muscle and brain is received. However, by
3 cm superficial brain is resolved from overlying muscle and
has a lower PCr/ATP ratio of 1.33 +0.5 and pHi of
7.03+0.02.
Histologically one of the astrocytomas was grade IV, three
were grade III, and three were grade II. No significant
necrosis was seen by microscopy in the samples taken at
surgery, which was performed within 24h of the phosphorus
signal being collected. The PCr, PME and pHi were all
elevated within the astrocytomas as shown in Figure 4. The
PDE was not significantly altered from normal brain at
similar depth (Table II).
The benign meningiomas all had significant necrosis
(>20 %) by histology. A typical MRS study is shown in
Figure 5. The PCr signal decreases from 2cm depth to
tumour centre, then increases, suggesting that PCr is low at
tumour centre. The signal at 5 cm is similar to normal brain.
The pHi was normal at this point (7.02). A study of the
contralateral side in this patient was also normal. The PME
and pHi were increased, but the PCr was reduced (Table II).
The PDE was significantly reduced when compared to
normal brain at similar depth.
Discussion
There are differences in pHi and phosphorus metabolism
between normal brain and primary brain tumours. These
tumours have more alkaline pHi than normal brain (7.03),
meningiomas (7.19) being more alkaline than gliomas (7.09).
The ratio of PME relative to ATP is elevated in these
tumours. The gliomas contained more PCr than normal
brain and meningiomas.
The PMRFI technique uses a Bl field gradient to identify
a phosphorus nucleus at a given depth. However, the Bi
field gradient is dependent on the tuning of the transmitter
coil and electromagnetic properties of the sample. Changes
in transmitter tuning do not effect spatial resolution, but
position in the image. We found that these variables could
be corrected for by using a sample vial placed in the middle
of the receiver coil. The phantom tests (Figures 1 and 2)
demonstrate the spatial and chemical resolution of this
technique. The phosphorus signal is received from a slice of
tissue resembling a biconvex disc, approximately 6.5cm in
diameter and 0.5cm deep, with a volume of 15cm3. Normal
anatomy of the head does not completely conform to these
dimensions, so any given slice may be comprised of a variety
of cell types. For example the slice at 1 cm may receive
phosphorus signal from muscle, scalp and some bone. The
slice at 3 cm will receive signal from brain, comprising
mainly grey matter and some white. The 5cm slice will
receive signal from mainly white matter. Likewise in the
Table I Normal brain phosphorus metabolites with depth
Depth pHi PCr/ATP PME/ATP PDE/ATP
(cm)
1 M 7.06+0.03 3.38+0.4 0.58+0.24 Not detected
2 M&B 7.03+0.02 3.13+0.5 0.83+0.15 1.75+0.3
3 B 7.03+0.02 1.33+0.3 0.7 +0.13 3.32+0.5
4 B 7.03+0.02 1.01+0.2 0.76+0.23 3.35+0.5
5 B 7.03+0.02 1.08+0.2 0.79+0.49 4.2 +0.5
M, temporalis muscle; B, brain tissue, mean+s.e.m. Seven normal
subjects were studied to estimate normal variation. Normal data at
4cm depth was used for comparison with the tumours investigated
in the same way.
Table II Phosphorus metabolites and pHi in tumours
Pt. Age Dexam.Grade pHi PME/ATP PCr/ATP PDE/ATP
Gliomas (astrocyomas)
1 50 + IV
2 22 + II
3 32 + III
4 48 - II
5 35 + II
6 28 -
7 49 _ III
Mean 41 III
s.d. 5
p
Meningioma
8 72
9 59
10 48
11 64
Mean 61
s.d. 10
p
+ BGN
BGN
BGN
BGN
7.12
7.07
7.11
7.02
7.06
7.06
7.10
7.08
+0.03
<0.05
7.17
7.18
7.15
7.28
7.19
+0.02
<0.05
1.01
1.64
0.83
1.06
0.98
1.78
0.82
1.16
+0.4
<0.05
1.02
1.12
1.05
1.12
1.08
+0.05
<0.05
3.29
3.13
1.01
1.49
1.39
3.09
1.24
2.09
+0.5
<0.05
0.74
0.34
0.81
0.66
0.64
+0.1
<0.5
3.03
4.54
2.60
4.76
3.70
3.03
1.78
3.33
+0.4
n.s.
1.78
2.22
2.84
2.85
2.42
+0.5
<0.1
All patients received phenytoin (300mg p.o. nocte) before PMRFI
and surgery. Dexamethasone (Dexam.) was prescribed (4mg p.o.
qds) as indicated to relieve symptoms due to raised intracranial
pressure. P values were derived using the Wilcoxon two-sample test
for non-parametric, non-paired samples.HUMAN PRIMARY BRAIN TUMOUR METABOLISM 433
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Figure 3 The diagram (a) describes the anatomical regions from which the phosphorus signal is received. The contour plot and
selected spectra (b) from a normal subject show signal from the receiver coil phantom (Ocm), temporalis muscle (1 cm), superficial
and deep brain.
glioma studies, due to the infiltrating nature of these
tumours, there will be a mixture of tumour and normal cells
in the observed tissue, producing an averaging of the
phosphorus signal received. This partial volume effect would
make the real intracellular tumour differences greater than
those observed in the imaged tissue.
The PMRFI technique has resolved overlying skeletal
muscle from deeper brain, as shown by the large difference
in PCr between the two tissues (PCr/ATP at 1 cm =3.36,
3cm=1.3) and pHi (1cm=7.06, 3cm=7.03). The brain
shows no significant variation with depth in PCr, PME or
pHi. However, the PDE increases significantly with depth
(PDE/ATP at 2cm= 1.75, 5cm=4.2). This would suggest
that there are no differences between grey and white matter
in phosphorus metabolites (PCr,Pi) involved in cellular ener-
getics and pHi.
The benign tumours studied had a significantly higher pHi
than normal brain at comparable depth. The elevated pHi
did not correlate with tumour grading (Table II) or rate of
cell division. The benign meningiomas (pHi 7.19) have a
lower S-phase fraction than astrocytomas (7.08) (Nishizaki et
al., 1988). This would suggest that rate of cell division is not
a direct determinant of pHi in these tumours. There are two
possible explanations for this pHi difference. First, the pHi
of normal glial cells may be more alkaline than neurones. As
the glial cells, with a more alkaline pHi, replace neurones
within the tumour, tissue pHi increases. This seems unlikely
since no pHi difference was observed with increasing depth
in the normal studies, despite changes in cell population
between grey and white matter. Alternatively there may be a
permanent change in the Na+/H+ antiport activity in the
tumour cells.
Modifying pHi by implanting and activating a yeast Na+/
H+ ATPase gene in murine fibroblasts causes tumours in
nude mice, whereas the control murine fibroblasts failed to
establish (Perona & Serrano, 1988), suggesting that the
alkaline pHi triggered uncontrolled mitosis.
Both tumour types had a raised PME content relative to
ATP. This rise in PME has been noted in malignant tumours
of the nervous system and in other tissues (Maris et al.,
BJC K
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Figure 4 The PMRFI data set from an occipital glioma (astrocytoma grade IV) localised by CT scan (a). The contour plot and
selected spectra (b) show elevated PCr throughout the tumour, with raised PME and slightly reduced PDE.
1985; Oberhaensli et al., 1986). Both in vitro and in vivo
MRS studies of rapidly dividing normal tissues have shown
a raised PME peak. Extracts of these tissues have suggested
that the PME peak is comprised mainly of phosphoethan-
olamine, a precursor in phospholipid synthesis (Brenton et
al., 1985). The tumours we studied had a small number of
mitotic figures per high power field, yet the PME remained
significantly raised, suggesting that the normal feed-back
control mechanisms regulating phospholipid metabolism are
altered such that PE accumulates within the cell.
The tumours observed differed in their PCr content rela-
tive to ATP. The PCr content of any cell is determined by
creatine phosphokinase (CPK) activity, with the following
biochemical reaction:
PCr+ADP+H +*-creatine+ATP
Compared to normal brain, meningiomas had a reduced
PCr, but PCr was raised in three of the astrocytomas. Low
PCr in the meningiomas was consistent with the necrosis
seen by microscopy. The necrosis was presumably due to an
unstable blood supply, periodically causing ischaemia and
infarction in sections of the tumour, resulting in PCr utilisa-
tion. However, the astrocytomas were receiving an adequate
blood supply with no evidence of significant tumour necro-
sis. The CPK BB isoenzyme has been histoimmuno-
chemically identified in astrocytes and neurones (Yoshimine
et al., 1985) of human brain, suggesting that change in
isoenzyme is not the cause for increases in PCr as the cell
population changes in the astrocytomas. The rise in PCr
observed in the astrocytomas may be due to an increased
creatine concentration or an increase in the ATP/ADP ratio.
The PDE peak is comprised of resonances of several
phosphodiester compounds found in the cytoplasm and cell
membranes. Some of these compounds are water soluble,
such as the breakdown products of phospholipids (glycero-
phosphocholine, glycerophosphoethanolamine). These water
soluble phosphodiesters can be extracted using perchloric
acid, but do not account for all the PDE observed in vivo.
Hydrophobic PDE compounds such as phosphatidylethano-
lamine and phosphatidylcholine found in the phospholipid
bilayer of cell plasma membrane and intracellular vesicles
may contribute the major portion of the in vivo PDE signal.
The rise of PDE with depth in normal brain may be due to
increased absolute concentration, or increased MRS 'visibi-
lity' of various phospholipids in myelin or the neural axon.HUMAN PRIMARY BRAIN TUMOUR METABOLISM 435
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Figure 5 The PMFRI data set (b) from a convexity meningioma, localised by CT scan (a), shows a reduction in PCr at a depth
corresponding to tumour centre. The PCr rises in displaced brain. The pHi is alkaline throughout.
MRS visibility depends on mobility of the phosphodiester
bond in the phospholipid layer, which may differ between
grey and white matter. The gliomas had a similar PDE
content to normal brain, suggesting that glial cells, whether
astrocyte or oligodendrocyte, contribute a significant portion
of the PDE signal. Interestingly the meningiomas have a
significantly reduced PDE content. 31P MRS of tissues
extracts may give more information on the source of the
PDE signal.
This study has demonstrated metabolic differences
between normal tissue and primary brain tumours in vivo.
The elevation of pHi and PME levels may be due to primary
faults in the metabolism of these benign tumours. These
changes are more likely to be related to the underlying
neoplastic process than merely a physiological consequence
of cell division. Further work is required to establish the
basic mechanism behind the increases in pHi and PME to
determine if these changes can be used to select patients for
different forms of chemotherapy.
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